23andMe, Inc., a leading personal genetics company, has announced the publication of the first-ever genome-wide association study of motion sickness. Published online on February 17, 2015 in the prestigious Human Molecular Genetics journal, this study is the first to identify genetic variants associated with motion sickness, a condition that affects roughly one in three people around the world. The title of this report is “Genetic Variants Associated with Motion Sickness Point to Roles for Inner Ear Development, Neurological Processes, and Glucose Homeostasis.” Motion sickness has been shown to have high heritability, meaning genetics accounts for a large part of why some people are more prone to motion sickness than others. Estimates indicate that up to 70 percent of the variation in risk for motion sickness is due to genetics. "Until now there's been a poor understanding of the genetics of motion sickness, despite it being a fairly common condition," said 23andMe scientist Dr. Bethann Hromatka, lead author of the study. "With the help of 23andMe customers, we've been able to uncover some of the underlying genetics of this condition. These findings could help provide clues about the causes of motion sickness and other related conditions, and how to treat them, which is very exciting." The new study, which involved the consented participation of more than 80,000 23andMe customers, found 35 genetic factors associated with motion sickness at a genome-wide significant level. Many of these factors, referred to as single-nucleotide polymorphisms (SNPs), are in or near genes involved in balance, and in eye, ear, and cranial development (e.g., PVRL3, TSHZ1, MUTED, HOXB3, HOXD3 genes). Other SNPs may affect motion sickness through nearby genes with roles in the nervous system, glucose homeostasis, or hypoxia.
Login Or Register To Read Full Story